Dementia in Down syndrome: unique insights for Alzheimer disease research

IT Lott, E Head - Nature Reviews Neurology, 2019 - nature.com
Virtually all adults with Down syndrome (DS) show the neuropathological changes of
Alzheimer disease (AD) by the age of 40 years. This association is partially due to …

The role of noradrenaline in cognition and cognitive disorders

N Holland, TW Robbins, JB Rowe - Brain, 2021 - academic.oup.com
Many aspects of cognition and behaviour are regulated by noradrenergic projections to the
forebrain originating from the locus coeruleus, acting through alpha and beta …

Risk factors for Down syndrome

F Coppedè - Archives of toxicology, 2016 - Springer
Down syndrome (DS) originates, in most of the cases (95%), from a full trisomy of
chromosome 21. The remaining cases are due to either mosaicism for chromosome 21 or …

ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism

R Desai, AE Frazier, R Durigon, H Patel, AW Jones… - Brain, 2017 - academic.oup.com
Although mitochondrial disorders are clinically heterogeneous, they frequently involve the
central nervous system and are among the most common neurogenetic disorders …

siRNA drug delivery across the blood–brain barrier in Alzheimer's disease

MI Sajid, FS Sheikh, F Anis, N Nasim… - Advanced Drug Delivery …, 2023 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disease with a few FDA-
approved drugs that provide modest symptomatic benefits and only two FDA-approved …

Rodent models in Down syndrome research: impact and future opportunities

Y Herault, JM Delabar, EMC Fisher… - Disease models & …, 2017 - journals.biologists.com
Down syndrome is caused by trisomy of chromosome 21. To date, a multiplicity of mouse
models with Down-syndrome-related features has been developed to understand this …

The early presentation of dementia in people with Down syndrome: a systematic review of longitudinal studies

BA Lautarescu, AJ Holland, SH Zaman - Neuropsychology review, 2017 - Springer
Adults with Down syndrome (DS) are at a very high risk of developing early onset
Alzheimer's disease (AD) due to trisomy of chromosome 21. AD is preceded by a prolonged …

Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome

M Carmona-Iragui, A O'Connor, J Llibre-Guerra… - …, 2024 - thelancet.com
Autosomal dominant Alzheimer's disease (ADAD) and Down syndrome (DS) constitute
genetic forms of Alzheimer's disease (AD). The study of these forms has been crucial in …

[HTML][HTML] Alzheimer's disease in Down syndrome: an overlooked population for prevention trials

A Strydom, A Coppus, R Blesa, A Danek… - Alzheimer's & Dementia …, 2018 - Elsevier
The discovery that adults with Down syndrome (DS) have neuropathological features
identical to individuals with sporadic Alzheimer's disease (AD) played a key role in the …

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome

P Zis, A Strydom - Free Radical Biology and Medicine, 2018 - Elsevier
Alzheimer's disease (AD) may affect in excess of 90% of individuals with Down syndrome
(DS) after age 60, due to duplication of the APP gene in trisomy of chromosome 21, with …